Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
230 participants
INTERVENTIONAL
2008-08-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PleuraSeal Post Market Study (Europe)
NCT00704171
Evaluation of the Effectiveness and Security of TenaTac® in the Prevention of Air Leaks in Thoracic Surgery
NCT06597604
Observational Study of TissuePatch SF in Prevention of Air Leaks Following Lung Resection
NCT06934486
Pneumostasis With Use of Bio-absorbable Mesh and Fibrin Sealant in Lung Resection
NCT04317924
Comparison of 40% Glucose Solution and Autologous Blood Patch Pleurodesis for Postoperative Air Leak After Lung Resections
NCT06936969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PleuraSeal Sealant Device
PleuraSeal Sealant System
Lung Sealant Device + standard tissue closing techniques (sutures/staples)
Standard Tissue Closure Techniques
Standard tissue closure techniques (sutures/ staples) alone
Control
Standard Tissue Closure Techniques
Standard tissue closure techniques (sutures/ staples) alone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PleuraSeal Sealant System
Lung Sealant Device + standard tissue closing techniques (sutures/staples)
Standard Tissue Closure Techniques
Standard tissue closure techniques (sutures/ staples) alone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Integra LifeSciences Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Confluent Surgical
Bedford, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LUN-06-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.